Literature DB >> 25541126

Pre-morbid body mass index and mortality after incident heart failure: the ARIC Study.

Umair Khalid1, Sameer Ather2, Chirag Bavishi3, Wenyaw Chan4, Laura R Loehr5, Lisa M Wruck6, Wayne D Rosamond5, Patricia P Chang7, Joe Coresh8, Salim S Virani9, Vijay Nambi10, Biykem Bozkurt9, Christie M Ballantyne1, Anita Deswal11.   

Abstract

BACKGROUND: Although obesity is an independent risk factor for heart failure (HF), once HF is established, obesity is associated with lower mortality. It is unclear if the weight loss due to advanced HF leads to this paradoxical finding.
OBJECTIVES: This study sought to evaluate the prognostic impact of pre-morbid obesity in patients with HF.
METHODS: In the ARIC (Atherosclerosis Risk In Communities) study, we used body mass index (BMI) measured ≥6 months before incident HF (pre-morbid BMI) to evaluate the association of overweight (BMI 25 to <30 kg/m(2)) and obesity (BMI ≥30 kg/m(2)) compared with normal BMI (18.5 to <25 kg/m(2)) with mortality after incident HF.
RESULTS: Among 1,487 patients with incident HF, 35% were overweight and 47% were obese by pre-morbid BMI measured 4.3 ± 3.1 years before HF diagnosis. Over 10-year follow-up after incident HF, 43% of patients died. After adjustment for demographics and comorbidities, being pre-morbidly overweight (hazard ratio [HR]: 0.72; 95% confidence interval [CI]: 0.58 to 0.90; p = 0.004) or obese (HR: 0.70; 95% CI: 0.56 to 0.87; p = 0.001) had a protective association with survival compared with normal BMI. The protective effect of overweight and obesity was consistent across subgroups on the basis of a history of cancer, smoking, and diabetes.
CONCLUSIONS: Our results, for the first time, demonstrate that patients who were overweight or obese before HF development have lower mortality after HF diagnosis compared with normal BMI patients. Thus, weight loss due to advanced HF may not completely explain the protective effect of higher BMI in HF patients.
Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  obesity paradox; outcomes; overweight; pre-morbid

Mesh:

Year:  2014        PMID: 25541126      PMCID: PMC4280076          DOI: 10.1016/j.jacc.2014.09.067

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  39 in total

1.  Body composition and prognosis in chronic systolic heart failure: the obesity paradox.

Authors:  Carl J Lavie; Ahmed F Osman; Richard V Milani; Mandeep R Mehra
Journal:  Am J Cardiol       Date:  2003-04-01       Impact factor: 2.778

2.  Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure.

Authors:  Caroline Kistorp; Jens Faber; Søren Galatius; Finn Gustafsson; Jan Frystyk; Allan Flyvbjerg; Per Hildebrandt
Journal:  Circulation       Date:  2005-09-12       Impact factor: 29.690

Review 3.  Obesity paradox, cachexia, frailty, and heart failure.

Authors:  Carl J Lavie; Alban De Schutter; Martin A Alpert; Mandeep R Mehra; Richard V Milani; Hector O Ventura
Journal:  Heart Fail Clin       Date:  2014-04       Impact factor: 3.179

4.  Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study.

Authors:  Salim Yusuf; Steven Hawken; Stephanie Ounpuu; Leonelo Bautista; Maria Grazia Franzosi; Patrick Commerford; Chim C Lang; Zvonko Rumboldt; Churchill L Onen; Liu Lisheng; Supachai Tanomsup; Paul Wangai; Fahad Razak; Arya M Sharma; Sonia S Anand
Journal:  Lancet       Date:  2005-11-05       Impact factor: 79.321

5.  The relationship between obesity and mortality in patients with heart failure.

Authors:  T B Horwich; G C Fonarow; M A Hamilton; W R MacLellan; M A Woo; J H Tillisch
Journal:  J Am Coll Cardiol       Date:  2001-09       Impact factor: 24.094

6.  Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity.

Authors:  Constantinos H Davos; Wolfram Doehner; Mathias Rauchhaus; Mariantonietta Cicoira; Darrel P Francis; Andrew J S Coats; Andrew L Clark; Stefan D Anker
Journal:  J Card Fail       Date:  2003-02       Impact factor: 5.712

7.  The relationship between cholesterol and survival in patients with chronic heart failure.

Authors:  Mathias Rauchhaus; Andrew L Clark; Wolfram Doehner; Constantinos Davos; Aidan Bolger; Rakesh Sharma; Andrew J S Coats; Stefan D Anker
Journal:  J Am Coll Cardiol       Date:  2003-12-03       Impact factor: 24.094

Review 8.  Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure.

Authors:  Carl J Lavie; Martin A Alpert; Ross Arena; Mandeep R Mehra; Richard V Milani; Hector O Ventura
Journal:  JACC Heart Fail       Date:  2013-04-01       Impact factor: 12.035

Review 9.  Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox.

Authors:  Carl J Lavie; Paul A McAuley; Timothy S Church; Richard V Milani; Steven N Blair
Journal:  J Am Coll Cardiol       Date:  2014-02-12       Impact factor: 24.094

10.  Obesity and the risk of heart failure.

Authors:  Satish Kenchaiah; Jane C Evans; Daniel Levy; Peter W F Wilson; Emelia J Benjamin; Martin G Larson; William B Kannel; Ramachandran S Vasan
Journal:  N Engl J Med       Date:  2002-08-01       Impact factor: 91.245

View more
  20 in total

Review 1.  Cardiometabolic Disease Leading to Heart Failure: Better Fat and Fit Than Lean and Lazy.

Authors:  Ambarish Pandey; Jarett D Berry; Carl J Lavie
Journal:  Curr Heart Fail Rep       Date:  2015-10

2.  Body Mass Index and Heart Failure Mortality: More Is Less?

Authors:  Michael E Hall
Journal:  JACC Heart Fail       Date:  2018-02-07       Impact factor: 12.035

3.  Myocardial Injury, Obesity, and the Obesity Paradox: The ARIC Study.

Authors:  Yashashwi Pokharel; Wensheng Sun; Salim S Virani; Vijay Nambi; Ron C Hoogeveen; Patricia P Chang; Chiadi E Ndumele; Scott D Solomon; Biykem Bozkurt; Elizabeth Selvin; Christie M Ballantyne; Anita Deswal
Journal:  JACC Heart Fail       Date:  2016-12-21       Impact factor: 12.035

Review 4.  Bariatric and Metabolic Surgery in Adolescents: a Path to Decrease Adult Cardiovascular Mortality.

Authors:  Andrew James Beamish; Torsten Olbers
Journal:  Curr Atheroscler Rep       Date:  2015-09       Impact factor: 5.113

Review 5.  Heart failure and kidney dysfunction: epidemiology, mechanisms and management.

Authors:  Joerg C Schefold; Gerasimos Filippatos; Gerd Hasenfuss; Stefan D Anker; Stephan von Haehling
Journal:  Nat Rev Nephrol       Date:  2016-08-30       Impact factor: 28.314

6.  Long-Term Weight Gain Associated With High Omentin Levels at Hospital Discharge Improves Prognosis of Patients Following Acute Heart Failure.

Authors:  Rosa M Agra-Bermejo; Rocio Gonzalez-Ferreiro; J Nicolos Lopez-Canoa; Alfonso Varela-Roman; Ines Gomez-Otero; Sonia Eiras; José R González-Juanatey
Journal:  J Cardiovasc Transl Res       Date:  2018-10-23       Impact factor: 4.132

Review 7.  Obesity and Cardiovascular Disease: a Risk Factor or a Risk Marker?

Authors:  Taher Mandviwala; Umair Khalid; Anita Deswal
Journal:  Curr Atheroscler Rep       Date:  2016-05       Impact factor: 5.113

8.  Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Preserved Ejection Fraction.

Authors:  Apostolos Tsimploulis; Phillip H Lam; Cherinne Arundel; Steven N Singh; Charity J Morgan; Charles Faselis; Prakash Deedwania; Javed Butler; Wilbert S Aronow; Clyde W Yancy; Gregg C Fonarow; Ali Ahmed
Journal:  JAMA Cardiol       Date:  2018-04-01       Impact factor: 14.676

9.  Body mass index and causes of death in chronic kidney disease.

Authors:  Sankar D Navaneethan; Jesse D Schold; Susana Arrigain; John P Kirwan; Joseph V Nally
Journal:  Kidney Int       Date:  2016-01-12       Impact factor: 10.612

Review 10.  The relationship between obesity and hypertension: an updated comprehensive overview on vicious twins.

Authors:  Massimo Leggio; Mario Lombardi; Elisa Caldarone; Paolo Severi; Stefania D'Emidio; Massimo Armeni; Veronica Bravi; Maria Grazia Bendini; Andrea Mazza
Journal:  Hypertens Res       Date:  2017-10-05       Impact factor: 3.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.